Rating History for Vitae Pharmaceuticals (VTAE) by Piper Sandler
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/20/2016 | N/A | Downgrade | Neutral (Overweight) |
N/A (N/A) |
20.85 (21.00) |
0.72% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/20/2016 | N/A | Downgrade | Neutral (Overweight) |
N/A (N/A) |
20.85 (21.00) |
0.72% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||